indirubin-3'-monoxime has been researched along with Neoplasms in 4 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meijer, L | 1 |
| Flajolet, M | 1 |
| Greengard, P | 1 |
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Evdokimov, NM | 1 |
| Magedov, IV | 1 |
| McBrayer, D | 1 |
| Kornienko, A | 1 |
| Wan, S | 1 |
| Chen, X | 1 |
| Yin, F | 1 |
| Li, S | 1 |
| Zhang, Y | 1 |
| Luo, H | 1 |
| Luo, Z | 1 |
| Cui, N | 1 |
| Chen, Y | 1 |
| Li, X | 1 |
| Kong, L | 1 |
| Wang, X | 1 |
1 review available for indirubin-3'-monoxime and Neoplasms
| Article | Year |
|---|---|
Pharmacological inhibitors of glycogen synthase kinase 3.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinas | 2004 |
3 other studies available for indirubin-3'-monoxime and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Isatin derivatives with activity against apoptosis-resistant cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, | 2016 |
Indirubin derivatives as bifunctional molecules inducing DNA damage and targeting PARP for the treatment of cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Damage; Neoplasms; Phthalazines; Poly(ADP-ri | 2023 |